Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Thrombomodulin Shapes Thrombo‐Inflammatory Interactions in Lupus Nephritis. Local targets link to admitted publications; unresolved targets remain external evidence.
Systemic Lupus Erythematosus
10.1038/nrdp.2016.39 · 2016 · External reference
Accrual of Thromboembolic Events and Antiphospholipid Syndrome in New‐Onset Systemic Lupus Erythematosus: A Population‐Based Inception Cohort Study
10.1136/rmdopen-2025-005795 · 2025 · External reference
Systematic Literature Review and Meta‐Analysis of Venous Thromboembolism Events in Systemic Lupus Erythematosus
10.1007/s40744-022-00513-1 · 2023 · External reference
Antiphospholipid Syndrome (APS) in Patients With Systemic Lupus Erythematosus (SLE) Implies a More Severe Disease With More Damage Accrual and Higher Mortality
10.1177/0961203320950477 · 2020 · External reference
ACR/EULAR Antiphospholipid Syndrome Classification Criteria
2023 · External reference
Risk Factors for Thrombosis and Primary Thrombosis Prevention in Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies
10.1002/art.24232 · 2009 · External reference
Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State
10.3899/jrheum.190250 · 2020 · External reference
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts
10.1002/art.39859 · 2017 · External reference
Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries‐Based Study
10.1002/acr.23015 · 2017 · External reference
Sjögren's Syndrome and Systemic Lupus Erythematosus: Links and Risks
10.2147/oarrr.s167783 · 2019 · External reference
The Frequency and Outcome of Lupus Nephritis: Results From an International Inception Cohort Study
10.1093/rheumatology/kev311 · 2016 · External reference
Risk and Protective Factors for Thrombosis in Systemic Lupus Erythematosus: Results From a Large, Multi‐Ethnic Cohort
10.1136/ard.2008.093013 · 2009 · External reference
Antiphospholipid Antibodies in Lupus Nephritis
10.1371/journal.pone.0158076 · 2016 · External reference
Assessing the Relative Impact of Lupus Nephritis on Mortality in a Population‐Based Systemic Lupus Erythematosus Cohort
10.1177/0961203319847275 · 2019 · External reference
Chronic Kidney Disease and Venous Thromboembolism: Epidemiology and Mechanisms
10.1097/mcp.0b013e32832ee371 · 2009 · External reference
Kidney Disease and Risk of Venous Thromboembolism: A Nationwide Population–Based Case–Control Study
10.1111/jth.12652 · 2014 · External reference
Definitions of and Contributions to Cardiovascular Disease in Systemic Lupus Erythematosus
10.3109/08916934.2013.856005 · 2014 · External reference
Systemic Lupus Erythematosus and Thrombosis
10.1186/s12959-015-0043-3 · 2015 · External reference
Molecular Mechanisms Underlying Thrombosis in Systemic Lupus Erythematosus—A Systematic Review
10.1016/j.semarthrit.2025.152707 · 2025 · External reference
Complement Alternative Pathway's Activation in Patients With Lupus Nephritis
10.1016/j.amjms.2017.01.005 · 2017 · External reference
Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus
10.1002/art.1780400928 · 1997 · External reference
Systemic Lupus Erythematosus in Denmark: Clinical and Epidemiological Characterization of a County‐Based Cohort
10.1080/030097498440958 · 1998 · External reference
The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited
2004 · External reference
Systemic Lupus Erythematosus Disease Activity Index 2000
2002 · External reference
The Reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in Patients With Systemic Lupus Erythematosus
10.1002/art.1780400506 · 1997 · External reference
Assays for the Functional Activity of the Mannan‐Binding Lectin Pathway of Complement Activation
10.1078/0171-2985-00145 · 2002 · External reference
Investigations on Collectin Liver 1
10.1074/jbc.m113.492603 · 2013 · External reference
An Enzyme‐Linked Immunosorbent Assay (ELISA) for Quantification of Human Collectin 11 (CL‐11, CL‐K1)
10.1016/j.jim.2011.10.010 · 2012 · External reference
Characteristics and Biological Variations of M‐Ficolin, a Pattern Recognition Molecule, in Plasma
10.1159/000218324 · 2010 · External reference
Effect of Capsulation of Opportunistic Pathogenic Bacteria on Binding of the Pattern Recognition Molecules Mannan‐Binding Lectin, L‐Ficolin, and H‐Ficolin
10.1128/iai.73.2.1052-1060.2005 · 2005 · External reference
Lectin Complement Pathway Proteins in Healthy Individuals
10.1111/cei.12909 · 2017 · External reference
Biological Variations of MASP‐3 and MAp44, Two Splice Products of the MASP1 Gene Involved in Regulation of the Complement System
10.1016/j.jim.2010.07.006 · 2010 · External reference
Levels of Mannan‐Binding Lectin‐Associated Serine Protease‐2 in Healthy Individuals
10.1016/j.jim.2003.08.012 · 2003 · External reference
MAp19, the Alternative Splice Product of the MASP2 Gene
10.1016/j.jim.2011.08.006 · 2011 · External reference
Complement Activation in Human Autoimmune Diseases and Mouse Models; Employing a Sandwich Immunoassay Specific for C3dg
10.1016/j.jim.2020.112866 · 2020 · External reference
Inter‐α‐Trypsin Inhibitor Heavy Chain 4 (ITIH4) as a Compensatory Protease Inhibitor in Hereditary Angioedema
10.1016/j.jaci.2024.03.028 · 2024 · External reference
The Anticoagulant Protein C Pathway
10.1016/j.febslet.2005.03.001 · 2005 · External reference
Protein C Anticoagulant and Cytoprotective Pathways
10.1007/s12185-012-1059-0 · 2012 · External reference
Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures
10.1055/a-1801-2055 · 2022 · External reference
Recombinant Human Soluble Thrombomodulin for Treatment of Thrombotic Microangiopathy Associated With Lupus Nephritis
10.3899/jrheum.111137 · 2012 · External reference
Endothelial Cell Activation and Glycocalyx Shedding ‐ Potential as Biomarkers in Patients With Lupus Nephritis
10.3389/fimmu.2023.1251876 · 2023 · External reference
Loss of the Endothelial Glycocalyx Links Albuminuria and Vascular Dysfunction
10.1681/asn.2012010017 · 2012 · External reference
Thrombomodulin in Systemic Lupus Erythematosus: Association With Clinical and Laboratory Parameters
10.1007/s002960050092 · 1999 · External reference
Serum Thrombomodulin‐a Reliable Marker of Disease Activity in Systemic Lupus Erythematosus (SLE): Advantage Over Established Serological Parameters to Indicate Disease Activity
10.1046/j.1365-2249.2000.01107.x · 2000 · External reference
Understanding Hypercoagulability With Nephrotic Syndrome: How the Clot Thickens
10.2215/cjn.0000000000000054 · 2023 · External reference
Alterations in Coagulation and Endothelial Function in Nephrotic Syndrome: A Multicenter, Cross‐Sectional Analysis
10.34067/kid.0000000865 · 2025 · External reference
The Lectin Pathway of Complement Activation in Patients With Systemic Lupus Erythematosus
10.3899/jrheum.171033 · 2018 · External reference
Collectin 11 (CL‐11, CL‐K1) is a MASP‐1/3‐Associated Plasma Collectin With Microbial‐Binding Activity
10.4049/jimmunol.1002185 · 2010 · External reference
Differentiating Between Activation via the Lectin or the Classical Complement Pathway in Patients With Systemic Lupus Erythematosus
10.1093/cei/uxad070 · 2023 · External reference
FcgRIIA Expression Accelerates Nephritis and Increases Platelet Activation in Systemic Lupus Erythematosus
10.1182/blood.2020004974 · 2020 · External reference